Treatment effect of pregabalin and etodolac in patients with paclitaxel-induced peripheral neuropathy -a verification study
Not Applicable
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000007974
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 144
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with a current or past history of gastrointestinal hemorrhage or peptic ulcer 2) Patients with a current or past history of serious complications such as cardiac, renal, hepatic, and hematological disorders 3) Patients with neuropathic pain due to diabetes mellitus or herpes zoster 4) Patients with a history of hypersensitivity to pregabalin or etodolac 5) Patients with neurological symptoms due to brain and/or bone metastases 6) Patients who used pregabalin or etodolac for treating pain possibly associated with paclitaxel 7) Other patients considered to be ineligible to participate in the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method